Sg3 Management, LLC Aurinia Pharmaceuticals Inc. Put Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$17.78 - $33.08 $544,068 - $1.01 Million	-30,600 Reduced 50.5%	30,000 $686,000
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $1.39 Million - $2.02 Million	-139,400 Reduced 69.7%	60,600 $785,000
Q1 2021 May 17, 2021	SELL	$12.3 - $18.73 $1.85 Million - $2.81 Million	-150,000 Reduced 42.86%	200,000 $2.6 Million
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $2.59 Million - $3.21 Million	200,000 Added 133.33%	350,000 $4.84 Million
Q3 2020 Nov 13, 2020	BUY	$13.19 - $16.66 $1.19 Million - $1.5 Million	90,000 Added 150.0%	150,000 $2.21 Million
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $847,200 - $1.1 Million	60,000 New	60,000 $975,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.